Indici bursieri Piețe bursiere Simboluri Statistici

Simbol HTBX
Heat Biologics Inc.

marți, 28 mai 2024, ora 19:39:39 EEST (UTC + 3)

Simbol HTBX
Simbol HTBX
Simbol eToro HTBX
MarketWatch HTBX
Finviz HTBX
Yahoo Finance HTBX
Google Finance HTBX
TradingView HTBX
Denumire Heat Biologics Inc.
ISIN US42237K4094
Sector Health Technology
Industrie Biotechnology
Monedă USD
Capitalizare bursieră 0,074 mld. USD
Beta 0,3368
EPS -1,1528
Profit anual -59,06%
Dată actualizare 20.01.2022

Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.

Istoric cotații

Data P/E Beta Capitalizare Dividend EPS Profit anual Preț
20.01.2022 0,00 0,3368 0,074 0,00% -1,1528 -59,06% $0,00

Pagină vizualizată de 80 ori și generată în 0,018716 secunde.